Preclinical research is about more than just data. It’s about the future: a future where you have identified the most promising candidate that meets its endpoints and succeeds in the market. That future is only achievable if your data is a result of rigorously designed studies using the most relevant models and executed with care and precision.
Your data will tell you a story, but is it the correct story? Being correct is everything, and we have spent decades developing our models to provide those correct answers. See why over 300 companies, including 18 of the top 20 pharmaceutical companies, trust PharmaLegacy for the answers to their preclinical drug development questions.
The Experience to Deliver
PharmaLegacy’s preclinical research services have supported over 600 IND applications. We have been trusted with critical studies by 18 of the top 20 pharmaceutical companies. Combined with the extensive experience of our scientific staff – over 15 years on average – PharmaLegacy empowers the advancement of your preclinical pipelines with clarity and confidence.
The Tools to Succeed
With 380,000 square feet of facility space, the latest in analytical equipment, and over 1,500 models spanning over 100 indications, PharmaLegacy is equipped to obtain the rich, high-fidelity data you need to make critical pipeline decisions and draft strong IND submissions. We maintain surplus availability of most models so we can start most studies nearly immediately. We can even initiate NHP studies in as little as two weeks.
Uncompromising Quality and Compliance
World-class preclinical research demands rigorous, verifiable quality. We ensure data integrity and regulatory confidence through strict adherence to international standards.
Our quality framework includes:
Choosing a preclinical CRO is a critical decision. At PharmaLegacy, we deliver the world-class execution and data integrity you expect, with the speed and efficiency you need to respect your budget and timelines.
Find out why clients who work with PharmaLegacy stay with PharmaLegacy. Tell us about your project, and let’s build a plan to move your preclinical pipelines forward.
“The study they delivered on a very reasonable budget was top notch […] The model was executed flawlessly.”
See why a top-20 pharmaceutical company trusts PharmaLegacy for its preclinical immuno-oncology trials.
